Full Text View
Tabular View
No Study Results Posted
Related Studies
Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease
This study has been completed.
Study NCT00001280   Information provided by National Institutes of Health Clinical Center (CC)

First Received on November 3, 1999.   Last Updated on March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mycoses
Additional conditions recognized in this trial
Granuloma
Granulomatous Disease, Chronic
More general conditions related to this trial
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Hematologic Diseases
Immune System Diseases
Immunologic Deficiency Syndromes
Leukocyte Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Pathologic Processes
Phagocyte Bactericidal Dysfunction
Interventions listed in this trial
itraconazole
Additional drug interventions recognized in this trial
Hydroxyitraconazole
More general drug interventions related to this trial
14-alpha Demethylase Inhibitors
Anti-Infective Agents
Antifungal Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services